An official website of the United States government

Here's how you know

Official websites use .mil

A .mil website belongs to an official U.S. Department of Defense organization in the United States.

Secure .mil websites use HTTPS

A lock () or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

JPEO-CBRND Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense

JPEO-CBRND

Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):

NEWS & MEDIA

Stay Connected with Social Media

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office below.

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as our – Command Brief, the Chemical Biological Defense Program's Enterprise Strategy, leadership biographies, COVID-19 fact sheets, and contracting overview documents.

Download Press Kit

JPEO-CBRND News

Two uniformed service members are in a tent. One wears PPE and a faceshield, while they use a nasal swab to collect a COVID-19 sample from the other Service member in uniform.

PHOTO INFORMATION

Download

Details

Mobile COVID-19 Swab Test Unit 1/4

NEW YORK (May 30, 2020) U.S. Army Pfc. Joshua Jenkins, assigned to the 44th Medical Brigade, conducts a COVID-19 swab test on U.S. Army Staff Sgt. Michael Ciske, at a mobile testing center outside the Javits Center in New York City, May 30, 2020. Military medical personnel assigned to the hospital collaborate as an integrated system in support of New York City medical system, as part of the Department of Defense COVID-19 response. U.S. Northern Command, through U.S. Army North, remains committed to providing flexible Department of Defense support to the Federal Emergency Management Agency for the whole-of-nation COVID-19 response. (U.S. Navy photo by Mass Communication Specialist 1st Class Kleynia R. McKnight)

On May 5, 2022, the Department of Defense (DOD), on behalf of and in coordination with the U.S. Department of Health and Human Services (HHS), awarded a $79.9 million contract to Premix, Inc. to establish production of a plastic compound primarily used for pipette tips, which are essential to COVID-19 and other diagnostic testing efforts. Premix, Inc. is a U.S. company and a subsidiary of Premix Oy, a Finnish company.

This industrial base expansion effort will allow Premix to onshore manufacturing capability to produce plastic resin suitable for pipette tips and tubes necessary to meet increased supply chain demands and other critical diagnostic activities. Increased production capacity will enable more than 200 million COVID-19 PCR tests monthly by September 2025 in Gaston County, North Carolina.

This award concludes industrial base expansion efforts made through a Commercial Solutions Opening (CSO) Area of Interest (AoI) opened in February 2021. The AoI solicited innovative solutions to rapidly mature and scale specific manufacturing capabilities within the diagnostic testing supply chain, such as raw materials, components, and equipment, used in the production of analyzers, reagents, test kits and other diagnostic materials for COVID-19 and other diagnostic testing.

The DOD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DOD’s Defense Assisted Acquisition Cell (DA2), and the Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT). This effort was funded through the American Rescue Plan Act (ARPA) to enable and support domestic industrial base expansion for critical medical resources.

###

In alignment with Department of Defense (DoD) Instruction 5400.17 and recent Executive Orders issued by the President, the U.S. Army has reviewed and adjusted its social media content to ensure compliance with DoD policies and priorities. As a result, certain posts have been removed, are in a process of being removed or modified to maintain consistency with federal guidance and uphold the integrity of our official communication channels. Content will be archived in accordance with DA PAM 25–403.

The U.S. Army remains committed to transparency, professionalism, and adherence to DoD directives while continuing to engage with our community in a manner that reflects our core values.

For any questions regarding social media policies, please refer to official DoD guidance available at https://www.esd.whs.mil/Directives/issuances/dodi/.